Aggressively find, test, trace and isolate to beat COVID-19

Affiliations

¹ Departments of Laboratory Medicine and Pathobiology, and Medicine (Matukas), University of Toronto; Division of Microbiology (Matukas), Department of Lab Medicine, and Department of Medicine, St. Michael's Hospital, Unity Health Toronto, Department of Medicine and Institute of Health Policy, Management and Evaluation (Dhalla), University of Toronto; Unity Health Toronto (Dhalla), Toronto, Ont.; editor-in-chief (Laupacis), CMAJ.

Editorial

Larissa M Matukas et al. CMAJ. 2020.

. 2020 Oct 5;192(40):E1164-E1165.

doi: 10.1503/cmaj.202120. Epub 2020 Sep 9.

¹ Departments of Laboratory Medicine and Pathobiology, and Medicine (Matukas), University of Toronto; Division of Microbiology (Matukas), Department of Lab Medicine, and Department of Medicine, St. Michael's Hospital, Unity Health Toronto, Department of Medicine and Institute of Health Policy, Management and Evaluation (Dhalla), University of Toronto; Unity Health Toronto (Dhalla), Toronto, Ont.; editor-in-chief (Laupacis), CMAJ.

No abstract available

Conflict of interest statement

Competing interests: See www.cmaj.ca/site/misc/cmaj_staff.xhtml for Andreas Laupacis. No other competing interests were declared.

Active testing of groups at increased risk of acquiring SARS-CoV-2 in Canada: costs and human resource needs.
Campbell JR, Uppal A, Oxlade O, Fregonese F, Bastos ML, Lan Z, Law S, Oh CE, Russell WA, Sulis G, Winters N, Yanes-Lane M, Brisson M, Laszlo S, Evans TG, Menzies D. Campbell JR, et al. CMAJ. 2020 Oct 5;192(40):E1146-E1155. doi: 10.1503/cmaj.201128. Epub 2020 Sep 9. CMAJ. 2020. PMID: 32907820 Free PMC article.

1. Areas in Canada with cases of COVID-19 as of September 7, 2020 [table]. In: Coronavirus disease 2019 (COVID-19): epidemiology update. Ottawa: Public Health Agency of Canada; updated 2020 Sept. 7. Available: https://health-infobase.canada.ca/covid-19/epidemiological-summary-covid... (accessed 2020 Sept. 8).
1. Furukawa NW, Brooks JT, Sobel J. Evidence supporting transmission of severe acute respiratory syndrome coronavirus 2 while presymptomatic or asymptomatic. Emerg Infect Dis 2020;26:e201595. - PMC - PubMed
1. Hellewell J, Abbott S, Gimma A, et al. Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts. Lancet Glob Health 2020;8:e488–96. - PMC - PubMed
1. Ng V, Fazil A, Waddell LA, et al. Projected effects of nonpharmaceutical public health interventions to prevent resurgence of SARS-CoV-2 transmission in Canada. CMAJ 2020. Aug. 9 [Epub ahead of print]. 10.1503/cmaj.200990. - DOI - PMC - PubMed
1. Campbell JR, Uppal A, Oxlade O, et al. Active testing of groups at increased risk of acquiring SARS-CoV-2 in Canada: costs and human resource needs. CMAJ 2020. Sept. 9 [Epub ahead of print]. 10.1503/cmaj.201128. - DOI - PMC - PubMed